BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 21220229)

  • 1. [Urinary and sexual disorders following localised prostate cancer management].
    Haab F; Beley S; Cornu JN; Culine S; Cussenot O; Hennequin C
    Bull Cancer; 2010 Dec; 97(12):1537-49. PubMed ID: 21220229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional results and treatment of functional dysfunctions after radical prostatectomy].
    Salomon L; Droupy S; Yiou R; Soulié M
    Prog Urol; 2015 Nov; 25(15):1028-66. PubMed ID: 26519966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erectile dysfunction and incontinence after prostatectomy. Treating the complications of surgery for prostate cancer].
    Schout B; Meuleman EJ
    Ned Tijdschr Geneeskd; 2012; 156(44):A4667. PubMed ID: 23114170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of erectile dysfunction in prostate cancer survivors.
    Sherer BA; Levine LA
    Curr Opin Urol; 2014 Jul; 24(4):401-6. PubMed ID: 24809413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
    Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
    BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical overview of the treatment of post-prostatectomy incontinence.
    Dorey G
    Br J Nurs; 2007 Oct 25-Nov 7; 16(19):1194-9. PubMed ID: 18026021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
    Basal S; Wambi C; Acikel C; Gupta M; Badani K
    BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Voiding dysfunction in prostate cancer].
    Prieto Chaparro L
    Arch Esp Urol; 2009 Dec; 62(10):773-85. PubMed ID: 20065527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing adverse effects of treatments for prostate cancer.
    Prescrire Int; 2012 Oct; 21(131):245. PubMed ID: 23185850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced prostate cancer: effective treatments, but many adverse effects.
    Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male urinary incontinence].
    de Boer TA; Heesakkers JP
    Ned Tijdschr Geneeskd; 2008 Apr; 152(14):797-802. PubMed ID: 18491821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of erectile dysfunction after prostatectomy: An update].
    Xu P; Wang YH
    Zhonghua Nan Ke Xue; 2017 Jul; 23(7):656-662. PubMed ID: 29723462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors.
    Chung E; Brock G
    J Sex Med; 2013 Feb; 10 Suppl 1():102-11. PubMed ID: 23387915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial experience combinating transobturator male sling and penile implant after radical prostatectomy].
    Cornu JN; Chanu T; Beley S; Sèbe P; Peyrat L; Ciofu C; Haab F
    Prog Urol; 2011 May; 21(5):349-53. PubMed ID: 21514538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.
    Kimura M; Caso JR; Bañez LL; Koontz BF; Gerber L; Senocak C; Donatucci CF; Vujaskovic Z; Moul JW; Polascik TJ
    BJU Int; 2012 Dec; 110(11 Pt C):E931-8. PubMed ID: 22520165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of erectile dysfunction after radical prostatectomy.
    Hall MC
    Semin Urol Oncol; 1995 Aug; 13(3):215-23. PubMed ID: 8521135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing and managing erectile dysfunction after prostatectomy for prostate cancer.
    Albaugh JA
    Urol Nurs; 2010; 30(3):167-177, 166. PubMed ID: 20648854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vacuum erection devices revisited: its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy.
    Pahlajani G; Raina R; Jones S; Ali M; Zippe C
    J Sex Med; 2012 Apr; 9(4):1182-9. PubMed ID: 21054791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.